Literature DB >> 11870622

The membrane attack complex of complement induces caspase activation and apoptosis.

Alma J Nauta1, Mohamed R Daha, Odette Tijsma, Bob van de Water, Francesco Tedesco, Anja Roos.   

Abstract

Activation of the terminal pathway of the complement system leads to insertion of terminal complement complexes (C5b-9) into the cell membrane, which may induce cytolysis. Recent data indicate that the terminal complement pathway can also result in apoptosis in vivo. To further define the cell death pathway induced by complement, we examined induction of apoptosis by complement in vitro. Rat mesangial cells opsonized with a complement-activating antibody and exposed to rat serum as a complement source underwent apoptotic cell death in a time- and dose-dependent fashion, as demonstrated by membrane exposure of phosphatidylserine and fragmentation of nuclei. No significant apoptosis was detected in either cultures treated with C6-deficient serum or in control cultures. The pan-caspase-inhibitor zVAD-fmk inhibited complement-induced apoptosis completely. In line with this observation, complement induced cleavage and activation of caspase 3. Importantly, cellular exposure to purified cytolytically inactive C5b-9, in the absence of antibody and early complement components, also resulted into caspase activation and apoptosis. Together, these results indicate that C5b-9 is involved in induction of apoptosis via a caspase-dependent pathway. Apoptosis as a consequence of complement-mediated cell damage may provide an explanation for the presence of apoptosis in inflammatory processes, for instance in hyperacute xenograft rejection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870622     DOI: 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

1.  Oxidative stress and the regulation of complement activation in human glaucoma.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Angela D Kain; David W Powell; Markus H Kuehn; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

Review 2.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

Authors:  Nirmal K Banda; Stephanie Hyatt; Alexandra H Antonioli; Jason T White; Magdalena Glogowska; Kazue Takahashi; Tod J Merkel; Gregory L Stahl; Stacey Mueller-Ortiz; Rick Wetsel; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

4.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

5.  Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.

Authors:  Courtney G Woods; Oksana Kosyk; Blair U Bradford; Pamela K Ross; Amanda M Burns; Michael L Cunningham; Pingping Qu; Joseph G Ibrahim; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-16       Impact factor: 4.219

6.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

Review 7.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

8.  Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab.

Authors:  Srinivas Mamidi; Marc Cinci; Max Hasmann; Volker Fehring; Michael Kirschfink
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

9.  Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Transl Res       Date:  2015-08-14       Impact factor: 7.012

10.  A comprehensive analysis of hydrogen peroxide-induced gene expression in tobacco.

Authors:  Steven Vandenabeele; Katrien Van Der Kelen; James Dat; Ilya Gadjev; Tom Boonefaes; Stijn Morsa; Pieter Rottiers; Luit Slooten; Marc Van Montagu; Marc Zabeau; Dirk Inze; Frank Van Breusegem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.